Amgen Inc. Increase (Decrease) in Other Operating Liabilities
Amgen Inc. (AMGN) reported Increase (Decrease) in Other Operating Liabilities of -$107.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingLiabilities · last filed 2026-08-05
- Amgen Inc. increase (decrease) in other operating liabilities for the quarter ending 2026-06-30 was -$32.00M, a 500.00% decline year-over-year.
- Amgen Inc. increase (decrease) in other operating liabilities for the quarter ending 2026-03-31 was -$75.00M.
- Amgen Inc. increase (decrease) in other operating liabilities for the quarter ending 2025-12-31 was -$76.00M, a 461.90% decline year-over-year.
- Amgen Inc. increase (decrease) in other operating liabilities for the quarter ending 2025-09-30 was -$10.00M.
- Amgen Inc. increase (decrease) in other operating liabilities for fiscal 2025 was -$156.00M.
- Amgen Inc. increase (decrease) in other operating liabilities for fiscal 2024 was -$51.00M.
- Amgen Inc. increase (decrease) in other operating liabilities for fiscal 2023 was -$222.00M.
- Amgen Inc. increase (decrease) in other operating liabilities for fiscal 2022 was -$182.00M.
| Period end | Increase (Decrease) in Other Operating Liabilities 3 month | Increase (Decrease) in Other Operating Liabilities 3 month as first filed | Increase (Decrease) in Other Operating Liabilities 6 month | Increase (Decrease) in Other Operating Liabilities 6 month as first filed | Increase (Decrease) in Other Operating Liabilities 9 month | Increase (Decrease) in Other Operating Liabilities 9 month as first filed | Increase (Decrease) in Other Operating Liabilities 12 month | Increase (Decrease) in Other Operating Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$32.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$107.00M 10-Q · filed 2026-08-05 | -$183.00M derived: sum of 3 quarters · filed 2026-08-05 | -$193.00M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2026-03-31 | -$75.00M 10-Q · filed 2026-05-01 | -$151.00M derived: sum of 2 quarters · filed 2026-05-01 | -$161.00M derived: sum of 3 quarters · filed 2026-05-01 | -$153.00M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-12-31 | -$76.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | -$86.00M derived: sum of 2 quarters · filed 2026-02-13 | -$78.00M derived: sum of 3 quarters · filed 2026-08-05 | -$156.00M 10-K · filed 2026-02-13 | ||||
| 2025-09-30 | -$10.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$2.00M derived: sum of 2 quarters · filed 2026-08-05 | -$80.00M 10-Q · filed 2025-11-05 | -$59.00M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-06-30 | $8.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$70.00M 10-Q · filed 2026-08-05 | -$49.00M derived: sum of 3 quarters · filed 2026-08-05 | -$88.00M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-03-31 | -$78.00M 10-Q · filed 2026-05-01 | -$57.00M derived: sum of 2 quarters · filed 2026-05-01 | -$96.00M derived: sum of 3 quarters · filed 2026-05-01 | -$73.00M derived: sum of 4 quarters · filed 2026-05-01 | ||||
| 2024-12-31 | $21.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | -$18.00M derived: sum of 2 quarters · filed 2026-02-13 | $5.00M derived: sum of 3 quarters · filed 2026-02-13 | -$51.00M 10-K · filed 2026-02-13 | ||||
| 2024-09-30 | -$39.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$16.00M derived: sum of 2 quarters · filed 2025-11-05 | -$72.00M 10-Q · filed 2025-11-05 | -$144.00M derived: sum of 4 quarters · filed 2026-02-13 | ||||
| 2024-06-30 | $23.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$33.00M 10-Q · filed 2025-08-06 | -$105.00M derived: sum of 3 quarters · filed 2026-02-13 | -$133.00M derived: sum of 4 quarters · filed 2026-02-13 | ||||
| 2024-03-31 | -$56.00M 10-Q · filed 2025-05-02 | -$128.00M derived: sum of 2 quarters · filed 2026-02-13 | -$156.00M derived: sum of 3 quarters · filed 2026-02-13 | -$200.00M derived: sum of 4 quarters · filed 2026-02-13 | ||||
| 2023-12-31 | -$72.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | -$100.00M derived: sum of 2 quarters · filed 2026-02-13 | -$144.00M derived: sum of 3 quarters · filed 2026-02-13 | -$222.00M 10-K · filed 2026-02-13 | $731.00M 10-K · filed 2024-02-14 | |||
| 2023-09-30 | -$28.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | -$72.00M derived: sum of 2 quarters · filed 2024-10-31 | -$150.00M 10-Q · filed 2024-10-31 | $334.00M 10-Q · filed 2023-10-31 | -$795.00M derived: sum of 4 quarters · filed 2025-02-14 | |||
| 2023-06-30 | -$44.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | -$122.00M 10-Q · filed 2024-08-07 | $402.00M 10-Q · filed 2023-08-04 | -$767.00M derived: sum of 3 quarters · filed 2025-02-14 | -$348.00M derived: sum of 4 quarters · filed 2025-02-14 | |||
| 2023-03-31 | -$78.00M 10-Q · filed 2024-05-03 | -$710.00M 10-Q · filed 2023-04-28 | -$723.00M derived: sum of 2 quarters · filed 2025-02-14 | -$304.00M derived: sum of 3 quarters · filed 2025-02-14 | $136.00M derived: sum of 4 quarters · filed 2025-02-14 | |||
| 2022-12-31 | -$645.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | -$226.00M derived: sum of 2 quarters · filed 2025-02-14 | $214.00M derived: sum of 3 quarters · filed 2025-02-14 | -$182.00M 10-K · filed 2025-02-14 | $761.00M 10-K · filed 2023-02-09 | |||
| 2022-09-30 | $419.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-31 | $859.00M derived: sum of 2 quarters · filed 2023-10-31 | $463.00M 10-Q · filed 2023-10-31 | $196.00M derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2022-06-30 | $440.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $44.00M 10-Q · filed 2023-08-04 | -$223.00M derived: sum of 3 quarters · filed 2024-02-14 | -$124.00M derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2022-03-31 | -$396.00M 10-Q · filed 2023-04-28 | -$663.00M derived: sum of 2 quarters · filed 2024-02-14 | -$564.00M derived: sum of 3 quarters · filed 2024-02-14 | -$162.00M derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2021-12-31 | -$267.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | -$168.00M derived: sum of 2 quarters · filed 2024-02-14 | $234.00M derived: sum of 3 quarters · filed 2024-02-14 | -$48.00M 10-K · filed 2024-02-14 | $356.00M 10-K · filed 2022-02-16 | |||
| 2021-09-30 | $99.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $501.00M derived: sum of 2 quarters · filed 2022-11-04 | $219.00M 10-Q · filed 2022-11-04 | $490.00M derived: sum of 4 quarters · filed 2023-02-09 | ||||
| 2021-06-30 | $402.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $120.00M 10-Q · filed 2022-08-05 | $391.00M derived: sum of 3 quarters · filed 2023-02-09 | $648.00M derived: sum of 4 quarters · filed 2023-02-09 | ||||
| 2021-03-31 | -$282.00M 10-Q · filed 2022-04-28 | -$11.00M derived: sum of 2 quarters · filed 2023-02-09 | $246.00M derived: sum of 3 quarters · filed 2023-02-09 | $749.00M derived: sum of 4 quarters · filed 2023-02-09 | ||||
| 2020-12-31 | $271.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-09 | $528.00M derived: sum of 2 quarters · filed 2023-02-09 | $1.03B derived: sum of 3 quarters · filed 2023-02-09 | $983.00M 10-K · filed 2023-02-09 | ||||
| 2020-09-30 | $257.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $760.00M derived: sum of 2 quarters · filed 2021-11-03 | $712.00M 10-Q · filed 2021-11-03 | $1.09B derived: sum of 4 quarters · filed 2022-02-16 | ||||
| 2020-06-30 | $503.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-04 | $455.00M 10-Q · filed 2021-08-04 | $836.00M derived: sum of 3 quarters · filed 2022-02-16 | $1.43B derived: sum of 4 quarters · filed 2022-02-16 | ||||
| 2020-03-31 | -$48.00M 10-Q · filed 2021-04-28 | $333.00M derived: sum of 2 quarters · filed 2022-02-16 | $930.00M derived: sum of 3 quarters · filed 2022-02-16 | $745.00M derived: sum of 4 quarters · filed 2022-02-16 | ||||
| 2019-12-31 | $381.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | $978.00M derived: sum of 2 quarters · filed 2022-02-16 | $793.00M derived: sum of 3 quarters · filed 2022-02-16 | $396.00M 10-K · filed 2022-02-16 | ||||
| 2019-09-30 | $597.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $412.00M derived: sum of 2 quarters · filed 2020-10-29 | $15.00M 10-Q · filed 2020-10-29 | $463.00M derived: sum of 4 quarters · filed 2021-02-09 | ||||
| 2019-06-30 | -$185.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29 | -$582.00M 10-Q · filed 2020-07-29 | -$134.00M derived: sum of 3 quarters · filed 2021-02-09 | $208.00M derived: sum of 4 quarters · filed 2021-02-09 | ||||
| 2019-03-31 | -$397.00M 10-Q · filed 2020-05-01 | $51.00M derived: sum of 2 quarters · filed 2021-02-09 | $393.00M derived: sum of 3 quarters · filed 2021-02-09 | $410.00M derived: sum of 4 quarters · filed 2021-02-09 | ||||
| 2018-12-31 | $448.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-09 | $790.00M derived: sum of 2 quarters · filed 2021-02-09 | $807.00M derived: sum of 3 quarters · filed 2021-02-09 | $1.21B 10-K · filed 2021-02-09 | ||||
| 2018-09-30 | $342.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | $359.00M derived: sum of 2 quarters · filed 2019-10-30 | $766.00M 10-Q · filed 2019-10-30 | $746.00M derived: sum of 4 quarters · filed 2020-02-12 | ||||
| 2018-06-30 | $17.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31 | $424.00M 10-Q · filed 2019-07-31 | $404.00M derived: sum of 3 quarters · filed 2020-02-12 | $641.00M derived: sum of 4 quarters · filed 2020-02-12 | ||||
| 2018-03-31 | $407.00M 10-Q · filed 2019-05-01 | $387.00M derived: sum of 2 quarters · filed 2020-02-12 | $624.00M derived: sum of 3 quarters · filed 2020-02-12 | $891.00M derived: sum of 4 quarters · filed 2020-02-12 | ||||
| 2017-12-31 | -$20.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-12 | $217.00M derived: sum of 2 quarters · filed 2020-02-12 | $484.00M derived: sum of 3 quarters · filed 2020-02-12 | $231.00M 10-K · filed 2020-02-12 | ||||
| 2017-09-30 | $237.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-31 | $504.00M derived: sum of 2 quarters · filed 2018-10-31 | $251.00M 10-Q · filed 2018-10-31 | $565.00M 10-Q · filed 2017-10-26 | $109.00M derived: sum of 4 quarters · filed 2019-02-13 | |||
| 2017-06-30 | $267.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-27 | $14.00M 10-Q · filed 2018-07-27 | $200.00M 10-Q · filed 2017-07-26 | -$128.00M derived: sum of 3 quarters · filed 2019-02-13 | -$49.00M derived: sum of 4 quarters · filed 2019-02-13 | |||
| 2017-03-31 | -$253.00M 10-Q · filed 2018-04-25 | -$129.00M 10-Q · filed 2017-04-27 | -$395.00M derived: sum of 2 quarters · filed 2019-02-13 | -$316.00M derived: sum of 3 quarters · filed 2019-02-13 | $59.00M derived: sum of 4 quarters · filed 2019-02-13 | |||
| 2016-12-31 | -$142.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-13 | -$63.00M derived: sum of 2 quarters · filed 2019-02-13 | $312.00M derived: sum of 3 quarters · filed 2019-02-13 | $323.00M 10-K · filed 2019-02-13 | $768.00M 10-K · filed 2017-02-14 | |||
| 2016-09-30 | $79.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-26 | $454.00M derived: sum of 2 quarters · filed 2017-10-26 | $465.00M 10-Q · filed 2017-10-26 | $100.00M derived: sum of 4 quarters · filed 2018-02-13 | ||||
| 2016-06-30 | $375.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-26 | $386.00M 10-Q · filed 2017-07-26 | $21.00M derived: sum of 3 quarters · filed 2018-02-13 | $224.00M derived: sum of 4 quarters · filed 2018-02-13 | ||||
| 2016-03-31 | $11.00M 10-Q · filed 2017-04-27 | -$354.00M derived: sum of 2 quarters · filed 2018-02-13 | -$151.00M derived: sum of 3 quarters · filed 2018-02-13 | $422.00M derived: sum of 4 quarters · filed 2018-02-13 | ||||
| 2015-12-31 | -$365.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-13 | -$162.00M derived: sum of 2 quarters · filed 2018-02-13 | $411.00M derived: sum of 3 quarters · filed 2018-02-13 | -$7.00M 10-K · filed 2018-02-13 | $1.00M 10-K · filed 2016-02-16 | |||
| 2015-09-30 | $203.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-28 | $776.00M derived: sum of 2 quarters · filed 2016-10-28 | $358.00M 10-Q · filed 2016-10-28 | $17.00M 10-Q · filed 2015-11-02 | $880.00M derived: sum of 4 quarters · filed 2017-02-14 | |||
| 2015-06-30 | $573.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-29 | $155.00M 10-Q · filed 2016-07-29 | -$164.00M 10-Q · filed 2015-08-05 | $677.00M derived: sum of 3 quarters · filed 2017-02-14 | $1.41B derived: sum of 4 quarters · filed 2017-02-14 | |||
| 2015-03-31 | -$418.00M 10-Q · filed 2016-05-02 | -$323.00M 10-Q · filed 2015-04-27 | $104.00M derived: sum of 2 quarters · filed 2017-02-14 | $839.00M derived: sum of 3 quarters · filed 2017-02-14 | $909.00M derived: sum of 4 quarters · filed 2017-02-14 | |||
| 2014-12-31 | $522.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14 | $1.26B derived: sum of 2 quarters · filed 2017-02-14 | $1.33B derived: sum of 3 quarters · filed 2017-02-14 | $759.00M 10-K · filed 2017-02-14 | $357.00M 10-K · filed 2015-02-19 | |||
| 2014-09-30 | $735.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02 | $805.00M derived: sum of 2 quarters · filed 2015-11-02 | $237.00M 10-Q · filed 2015-11-02 | $368.00M derived: sum of 4 quarters · filed 2016-10-31 | ||||
| 2014-06-30 | $70.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | -$498.00M 10-Q · filed 2015-08-05 | -$367.00M derived: sum of 3 quarters · filed 2016-10-31 | $0.00 derived: sum of 4 quarters · filed 2016-10-31 | ||||
| 2014-03-31 | -$568.00M 10-Q · filed 2015-04-27 | -$437.00M derived: sum of 2 quarters · filed 2016-10-31 | -$70.00M derived: sum of 3 quarters · filed 2016-10-31 | -$110.00M derived: sum of 4 quarters · filed 2016-10-31 | ||||
| 2013-12-31 | $131.00M derived: 8-K 12 month − 10-Q 9 month · filed 2016-10-31 | $498.00M derived: sum of 2 quarters · filed 2016-10-31 | $458.00M derived: sum of 3 quarters · filed 2016-10-31 | $116.00M 8-K · filed 2016-10-31 | $221.00M 10-K · filed 2014-02-24 | |||
| 2013-09-30 | $367.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-29 | $327.00M derived: sum of 2 quarters · filed 2014-10-29 | -$15.00M 10-Q · filed 2014-10-29 | -$9.00M derived: sum of 4 quarters · filed 2015-02-19 | ||||
| 2013-06-30 | -$40.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | -$382.00M 10-Q · filed 2014-08-05 | -$376.00M derived: sum of 3 quarters · filed 2015-02-19 | $128.00M derived: sum of 4 quarters · filed 2015-02-19 | ||||
| 2013-03-31 | -$342.00M 10-Q · filed 2014-04-30 | -$336.00M derived: sum of 2 quarters · filed 2015-02-19 | $168.00M derived: sum of 3 quarters · filed 2015-02-19 | $361.00M derived: sum of 4 quarters · filed 2015-02-19 | ||||
| 2012-12-31 | $6.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-19 | $510.00M derived: sum of 2 quarters · filed 2015-02-19 | $703.00M derived: sum of 3 quarters · filed 2015-02-19 | $165.00M 10-K · filed 2015-02-19 | ||||
| 2012-09-30 | $504.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-29 | $697.00M derived: sum of 2 quarters · filed 2013-10-29 | $159.00M 10-Q · filed 2013-10-29 | -$15.00M derived: sum of 4 quarters · filed 2014-02-24 | ||||
| 2012-06-30 | $193.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | -$345.00M 10-Q · filed 2013-08-06 | -$519.00M derived: sum of 3 quarters · filed 2014-02-24 | $463.00M derived: sum of 4 quarters · filed 2014-02-24 | ||||
| 2012-03-31 | -$538.00M 10-Q · filed 2013-05-03 | -$712.00M derived: sum of 2 quarters · filed 2014-02-24 | $270.00M derived: sum of 3 quarters · filed 2014-02-24 | $485.00M derived: sum of 4 quarters · filed 2014-02-24 | ||||
| 2011-12-31 | -$174.00M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-24 | $808.00M derived: sum of 2 quarters · filed 2014-02-24 | $1.02B derived: sum of 3 quarters · filed 2014-02-24 | $773.00M 10-K · filed 2014-02-24 | ||||
| 2011-09-30 | $982.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $1.20B derived: sum of 2 quarters · filed 2012-11-06 | $947.00M 10-Q · filed 2012-11-06 | |||||
| 2011-06-30 | $215.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08 | -$35.00M 10-Q · filed 2012-08-08 | ||||||
| 2011-03-31 | -$250.00M 10-Q · filed 2012-05-08 | |||||||
| 2010-12-31 | $234.00M 10-K · filed 2013-02-27 | |||||||
| 2009-12-31 | $353.00M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GILEAD SCIENCES, INC. (GILD) | United States | $185.522B | -48.37 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |